A German-U.S. coronavirus vaccine has been administered to human test subjects in the U.S., the companies involved reported on Tuesday. After preliminary tests in Germany, Biontech of Mainz and U.S.-based Pfizer are advancing the clinical trial of BNT162, an mRNA vaccine, in the U.S. As many as 360 healthy volunteers will be vaccinated in U.S. study — initially only with test subjects between ages 18 and 55 but later also with older participants. The next...

The WHO Country Representative, Fiona Braka, while fielding questions, stated that research was going on globally for a COVID-19 vaccine. According to Braka, no fewer than 89 products are undergoing development. He stated, “Research is going on globally to study the genetics of the virus. This helps us to develop a vaccine. Thanks to the rapid sharing of genetic data from countries, we are able to advance the production of vaccines. “We do acknowledge the...

Dr. Tedros Ghebreyesus, the Director-General of World Health Organisation (WHO), says leaders from 40 countries have pledged to support research and development for vaccine, diagnostics and therapeutics with 7.4 billion euros. Ghebreyesus disclosed this at a news conference on Monday in Geneva, explaining that the fund would be used to carry out activities for COVID -19 research and development. In a speech posted on the WHO website, Ghebreyesus was quoted as saying: “ACT Accelerator, to...

Scores of European countries further relaxed coronavirus restrictions on Monday, with experts the world over – and residents of those countries affected – waiting to see if they strike the right balance between safety and openness. We take a look at some of the changes, although this is by no means a comprehensive list. In Austria, some 100,000 final-year students returned to vocational and high-schools for the first time since mid-March. Also on Monday, elderly...